Surveillance for Factor VIII Inhibitor Development in the Canadian Hemophilia A Population Following the Widespread Introduction of Recombinant Factor VIII Replacement Therapy

By Giles A.R.   Rivard G.E.   Teitel J.   Walker I.  

Transfusion and Apheresis Science, Vol. 19, Iss. 2, 1998-06 ,pp. : 139-148

Elsevier

Access to resources Recommend Favorite

Expression of Factor VIII in Recombinant and Transgenic Systems

By Soukharev S.   Hammond D.   Ananyeva N.M.   Anderson J.A.M.   Hauser C.A.E.   Pipe S.   Saenko E.L.  

Blood Cells, Molecules, and Diseases, Vol. 28, Iss. 2, 2002-02 ,pp. : 234-248

Academic Press

Access to resources Recommend Favorite

Pattern of factor VIII inhibitors in patients with hemophilia A in the north east of Iran

By Modaresi A. R.   Torghabeh H. Mansouri   Pourfathollah A. A.   Shooshtari M. Mahmoodian   Yazdi Z. Rezaie  

Hematology, Vol. 11, Iss. 3, 2006-06 ,pp. : 215-217

Maney Publishing

Access to resources Recommend Favorite

Optimizing clotting factor replacement therapy in hemophilia: A global need

By Srivastava Alok  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 229-230

Maney Publishing

Access to resources Recommend Favorite

Anti-factor VIII Antibodies (Inhibitors) in Hemophilia A: In Dire Need of Basic and Therapeutic Research

By Kaveri Srini  

Clinical Reviews in Allergy and Immunology, Vol. 37, Iss. 2, 2009-10 ,pp. : 55-57

Humana Press, Inc

Access to resources Recommend Favorite